Promoter Bank clone, Human small proline-rich protein 2F (SPRR2F) promoter
Alternative name | p1998-57F |
---|---|
Clone info. | PCR amplified human small proline-rich protein 2F (SPRR2F) promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Cloned fragment: 153116581 to 153113487(NC_000001.11); relatively -3065 to +30, where +1 corresponds to 1 nt of NM_001014450.3. |
Comment | PCR cloning, forward primer, 1998 F2: 5' ctactcacgtccagccccacctttg 3'; reverse primer, 1998 R2: 5' gcagatcggtgcttaggtaccagga 3'; Entire sequence of promoter region has not been confirmed. Promoter activity has not been analyzed. (reference: J. Biol. Chem., 276, 19231-19237, 2001, PMID:11279051) |
Vector backbone | pKM2L (RDB04026) (Plasmid) |
Size of vector backbone | 4.2 kb |
Selectable markers | Kan^r |
Gene/insert name | Human small proline-rich protein 2F genomic DNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05810 | pKM2L-phSPRR2F(2) | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pKM2L-phSPRR2F(2) was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05810). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB05810_A5Kkp1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: PRE_rev Sequence file: RDB05810_A5Kka.seq ![]() |
---|
>05810_5810_A5Kk_M13(-40)_H05_23.ab1 1 AGGAAGGGTG CAAGGGCTTG CATGGCCTGC AGGTCATTTA AATAGGGATA ACAGGGTAAT 61 GATTAAGATC TCGAGCTCTA AGCTTCACAT ATGCATGCAC TAGTGGCCTA CTCACGTCCA 121 GCCCCACCTT TGGTGTTTGG CCAGAGATGC TTAAAAGGAA AAAGATCATT ATCTCACTAA 181 TTGAGCTATG GACAGACTTG TCTCTTGTTA GCTTTTCAAA GCAGAATTTT AAGTCTTTAC 241 AAAATAATAG GTAACATTTG GAGAATATTT TGAAAAGGAA AATAAGAAAA TAAAAATCAT 301 CTGTAATTAC ACCAACCAAA CAGAATCACA TTTAATAAAA TGTTTTAGGT ATTTCTTATC 361 TTTTCATACA TAAATGTTAA AATGTTGTCA TGCTTTATAT ATGCTTTTAC TATAATTTGA 421 ATGTTTTAAA TAATATTAAA TAGTCTTCTA AAACATCCTC CCTAATGATC TTAAGAATTC 481 TGCAACATTA ATGTCCCATA ATTTATCTGA TTAAGCAAAA TTATGGAATA ATGATGGAAT 541 GTAAGCCTAT ATTCAGGAAT AAAACAGAAG CAGAAATTCA CAGAGACTTA GAGTGATTTA 601 TTTAAGGCTA GGAAAATCTT CCCACAATTC CTGTTTCTTC TTGCATGTTT GATGGCAGAA 661 TATTAATTTG CCAGGACTAT TTTGTTTAAT GGTGTAAAAT GCATAGTAGT AAAATGTGAG 721 ATAGAAGTTG AATCAAGAAT AACACAAAAG TTCAAAAGCT TTTGTTCTTT CTTGTCATTT 781 TTATGTAGTA ATGATTTAAA CTTAATAATC CCTTCAAAAA TTATGGAGTA AAAGTAGGAG 841 AAATGGACCT AAGGCTATCA GACTGTTAAA GAACATAAAG CTAAACTTCT TTATATATGT 901 GGAGAGATAA TAGAAAGGTA GATGGATAGA TAGATGACAC ATTAGATAGA TAGAAGATAG 961 ATAGATAGAT AGATAGACAC ACACCCATGG TGGGTATGTG TGTGTGTGTA AAGTATGCCT 1021 TGCTGCATGT CTCAGGGCCC TGGATGTCCT AACTTGGGGA AGCTGTGACT GTTAGCTGCC 1081 CCCTCTTCAT GTGTGGCCAT TTCCTCATGT AGCCTGATCT GTGAGAAACT CTGAATTTCC 1141 AAGGTTCACT TGTAAAAGTT GAGAGCCTGG TCTCGTTGA // |
Primer: PRE,mRFP1,T2A,TetR Sequence file: RDB05810_A5Kkb.seq ![]() |
>05810_5810_A5Kk_phRLR2_B06_06.ab1 1 AATTTCTTTT TTCTGAAAGC CCAGTTTCTA TTGGTCTCCT TAAACCTGTC TTGTAACCTT 61 GATACTTACC TGCCCAGTGC CTCACGACCA ACTTCTGCAG TACCCGGGTG AATTCTACGC 121 GTCGACAGGC GCAGATCGGT GCTTAGGTAC CAGGAGTTTA GGAGTCGTGC AGCAGAAAAC 181 CTCTTTATAG GGCCTGCTAC CCCTCCCAGC AGAAAGTGTA ACTGCCAAAA GCTACACTTA 241 TCCAGTAATT TCTTAAGCCA AATGCAAATT TATCCACAAC TGGCCTGACA GTGATTATCA 301 AACTAGGAAA TATCCTGTTC TGGGATCTCC CCACTGGGTT AAGTGCTCCT GACTCACAGA 361 GGCCCTGCCT TAGATCTCAG TTTCAGTGAC CTATGGCAAA GAGGGACTTG GGGGATTCTC 421 TAACTGGTGG TCAAGGGCTC TCTTTTTTGA CTGGGGGCAA TGATCCTTTC CTGTCTTACA 481 CCTTCCCTAA ATCATAAAAC TTCCTGTCCT GATCCACTTT ACTGAATGCC ATATTGTTGT 541 ACATGAACCC ATCTCCACCT CTACTTTCCT TGTACAATTT GCCAATGCGC TAAAAGGAAG 601 GAGAGACCTA ACAAAGGCCT GGGTTCTGGT CCCAGATTTT TTTTTTTTTT TTTTTTTTTT 661 TTTTGTTGCT AAGTTGTGTG ACCACAGGCA GGTCACCTCT CCTCCCTGTG ATTATAAGCA 721 GGGGAGAATC ATACTTACCT CTGGAGATGG GAGCTGACCG CATTGTGCCA TCTGCTGACC 781 CTGTTCAAGC CAGAAACTTT CTCCTCCACT TCTATCTTTC TCTCTCATAG AACCCTGGAT 841 TTTACGATTT TCCTTTCCTC TTTGAAAGCT GTCTTCTCCA CCCCAATTTG TACAGGCAAT 901 TGTCACCTGG GACAGATTCC AGAGTGACAG CCAGTCTCCC CAGCACATTT GCTACTTGCT 961 GCCATTAAGG ATGTATACTA GCGCCTTTTT ATTTATAAAA ATGTATTCTT TGCTACACAT 1021 TAAGGGAAAC GGGAGAGACA TGAAACAAAA TTACAGCATT CATTCAAAAT CTTATGTTAT 1081 TGAACATGCT ATATGATCCT GCGCTACTAT AGAGAACAAT CTGGCATAGA CCTCACATTA 1141 TCCATATGGG TGCAAATAAA CTG // |
Primer: pAxCALNL_F1 Sequence file: RDB05810_A5Kkc.seq ![]() |
>05810_5810_A5Kk_pAxCALNL_F1_A06_03.ab1 1 ACAATATAAT CTTATCATGT CTGCTCGAGC GGCCGCTCTA GAATTACTGC TCGTTCTTCA 61 GCACGCGCTC CACGAAGCTC TTGATGTACT TACCCATTTC ATCTGGAGCG TCCTCCTGGC 121 TGAAGTGGAG GCCCTTCACC TTCACGAACT CGGTGTTAGG GAACTTCTTA GCTCCCTCGA 181 CAATAGCGTT GGAAAAGAAC CCAGGGTCGG ACTCGATGAA CATCTTAGGC AGATCGTCGC 241 TGGCCCGAAG GTAGGCGTTG TAGTTGCGGA CAATCTGGAC GACGTCGGGC TTGCCTCCCT 301 TAACGAGAGG GATCTCGCGA GGCCAGGAGA GGGTAGGCCG TCTAACCTCG CCCTTCTCCT 361 TGAATGGCTC CAGGTAGGCA GCGAACTCCT CAGGCTCCAG TTTCCGCATG ATCTTGCTTG 421 GGAGCATGGT CTCGACGAAG AAGTTATTCT CAAGCACCAT TTTCTCGCCC TCTTCGCTCT 481 TGATCAGGGC GATATCCTCC TCGATGTCAG GCCACTCGTC CCAGGACTCG ATCACGTCCA 541 CGACACTCTC AGCATGGACG ATGGCCTTGA TCTTGTCTTG GTGCTCGTAG GAGTAGTGAA 601 AGGCCAGACA AGCCCCCCAG TCGTGGCCCA CAAAGATGAT TTTCTTTGGA AGGTTCAGCA 661 GCTCGAACCA AGCGGTGAGG TACTTGTAGT GATCCAGGAG GCGATATGAG CCATTCCCGC 721 TCTTGCCGGA CTTACCCATT CCGATCAGAT CAGGGATGAT GCATCTAGCC ACGGGCTCGA 781 TGTGAGGCAC GACGTGCCTC CACAGGTAGC TGGAGGCAGC GTTACCATGC AGAAAAATCA 841 CGGCGTTCTC GGCGTGCTTC TCGGAATCAT AGTAGTTGAT GAAGGAGTCC AGCACGTTCA 901 TTTGCTTGCA GCGAGCCCAC CACTGAGGCC CAGTGATCAT GCGTTTGCGT TGCTCGGGGT 961 CGTACACCTT GGAAGCCATG GTGGCTAGCC TATAGTGAGT CGTATTAAGT ACTCTAGCCC 1021 TTAGAGCTGT AATTGAACTG GGAGTGACAC CTGTGAGAGA AAGGCAAAGT GAATGGTCAG 1081 TAGACCATAG TGCCTATCAG AACGCAGAGT CTCCTCTTGT CTCGACAGCC AGGTTCCATG 1141 TCTCGTAACT GATCTGTAAC // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content